Current status of dietary measures in patients with advanced-stage chronic renal failure

Czech version

Authors: Anna Maršáková; Karolína Krátká; Petra Bachroňová; Ivan Rychlík
Authors‘ workplace: I. interní klinika 3. LF UK a FN Královské Vinohrady Praha
Published in: Vnitř Lék 2020; 66(6): 10-13
Category:

Overview

For patients with advanced chronic kidney disease (CKD) appropriately chosen and timely initiated dietary measures, as a complement to drug therapy, may slow the progression of the disease and delay the need for dialysis treatment. According to the results, dietary protein restriction may play a very important in management of such a patient. The effect of low protein diet is given by the early initiation and well cooperation of patients. The low protein diet with supplementation of ketoanalogues of amino acids is an attractive intervention to help maintain good nutritional status of patients and also have a positive role in calcium phosphate metabolism. Depending on the level of CKD´s progression it should not be forgotten either the fluid balance and the limitation of the intake of salt and phosphorus in the diet which may also have an unfortunate effect on the course of the disease.

Keywords:

fluid and mineral balance – chronic kidney disease – ketoanalogue – low protein diet

Sources

1. Fouque D, Laville M, Boissel JP, et al. Controlled low protein diets in chronic renal insufficiency: meta-analysis. Br Med J 1992; 304: 216–220.

2. Helal I, Fick-Brosnahan GM, Reed-Gitomer B, et al. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol. 2012; 8: 293–300.

3. Teplan V, Mengerová O. Dieta a nutriční opatření u chorob ledvin a močových cest. Praha: Mladá fronta 2010: 35–115.

4. Hahn D, Hodson EM, Fouque D. Low protein diets for non-diabetic adults with chronic kidney disease. Cochrane Database Syst Rev 2018; 10: CD001892.

5. Barril G, Nogueira A, Ruperto López M, et al. Influence of dietary protein intake on body composition in chronic kidney disease patients in stages 3-5: A cross-sectional study. Nefrologia 2018; pii: S0211-6995(18)30116-4.

6. Aparicio M, Bellizi V, Chauveau P, et al. Protein restricted diet plus keto/amino acids – a valid therapeutic approach for chronic kidney disease. J Ren Nutr 2012; 22(Suppl. 2): S1–S24.

7. Aparicio M, Bellizi V, Chauveau P, et al. Do ketoanalogues still have a role in delaying dialysis initiation in CKD predialysis patients? Sem Dial 2013; 26: 714–719.

8. Garneata L, Mircescu G. Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease. J Ren Nutr 2013; 23: 210–213.

9. Garneata L, Stancu A, et al. Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. J Am Soc Nephrol 2016; 27: 2164–2176.

10. Vachek J, Zakiyanov O, Tesař V. Sekundární dyslipidemie při onemocnění ledvin. AtheroRev 2016; 1: 80–88.

11. Reiss AB, Miyawaki N, Moon J, et al. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies. Atherosclerosis 2018; 278: 49–59.

12. Notaras S, Conti J. A qualitative analysis of eating behaviour change for patients with diabetes and non-dialysis dependent chronic kidney disease stages 4–5. J Ren Care 2018; 44: 219–228.

13. Vachek J, Tesař V. Hyperfosfatémie. Remedia 2017; 27: 278–280.

14. Dusilová Sulková S. Renální osteopatie a možnosti léčby. Remedia 2009; 19: 183–189.

15. Sotorník I, Bubeníček P. Léčba renální osteopatie. In: Teplan V et al. Praktická nefrologie. Praha: Grada Publishing 2006: 103–105.

16. Teplan V. Pharmacological features of a keto amino acids. Am J Nephrol 2005; 25(Suppl. 1): 13–14.